Loading organizations...
Loading organizations...

Anomaly Bio: Biotechnology company using synthetic biology to produce sustainable bio-based ingredients for nutrition, crop protection, and personal care.
Based in Singapore, Anomaly Bio is a biotechnology company that engineers microbes into microfactories to produce next-generation biobased ingredients through precision fermentation. Operating strictly as a B2B ingredient supplier, the enterprise focuses on sustainably manufacturing novel molecules for the global nutrition, crop protection, and personal care sectors. By utilizing synthetic biology, the organization provides commercial alternatives to traditional chemical or agricultural sourcing methods that deplete natural resources. To scale these biomanufacturing capabilities, the startup has successfully raised $2.6 million in pre-seed funding. This financial backing includes direct investments from venture capital firm Pebblebed, Notion executive Akshay Kothari, and Solugen cofounder Sean Hunt, alongside strategic program participation with Mars Petcare and Big Idea Ventures. Originally launched as a vegan pet supplement brand called Pawsible Foods, the rebranded enterprise was founded in 2023 by Armaan Dhanda and Samyak Baid.
Anomaly Bio has raised $2.6M across 1 funding round.
Anomaly Bio has raised $2.6M in total across 1 funding round.
Anomaly Bio has raised $2.6M in total across 1 funding round.
Anomaly Bio's investors include Pebblebed, Akshay Kothari, Eben Bayer, Mithun Sacheti, Sean Hunt.
Anomaly Bio has raised $2.6M across 1 funding round. Most recently, it raised $2.6M Pre-Seed in November 2025.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Nov 12, 2025 | $2.6M Pre-Seed | Pebblebed | Akshay Kothari, Eben Bayer, Mithun Sacheti, Sean Hunt |